Clinical Trials · NCT01234168

A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea

Name: A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedN/ALanreotide

Phase: N/A
Recruitment status: Completed
Sponsor: Ipsen
Enrollment: 340
Start date: Oct 2010
Locations: 57 sites, 8 countries
Primary endpoint: Subject's overall satisfaction regarding control of diarrhea

View Lanreotide compound reference